Venetoclax Monotherapy in R/R CLL With del(17p)

Slideset - Single-agent venetoclax is active and achieved deep responses in relapsed/refractory CLL with del(17p).

Source: Clinical Care Options Leukemia - December 14, 2015 Category: Hematology Source Type: research